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Abstract
Propionibacterium acnes is the most frequent anaerobic pathogen found in spondylodiscitis. A documented case required microbiological
proof of P. acnes with clinical and radiological confirmation of inflammation in a localized region of the spine. Microbiological samplings
were obtained by surgery or aspiration under radiological control. Twelve males and 17 females (median age, 42 years) with spondylo-
discitis due to P. acnes were diagnosed within the last 15 years. Three patients were immunosuppressed. All patients reported back pain
as the main symptom, and most were afebrile. Three patients had a peripheral neurological deficit, one a motor deficit, and two a sen-
sory deficit attributable to the infection; and six patients had an epidural abscess. The most frequent risk factor was surgery, which was
present in the history 28 of 29 (97%) patients. The mean delay between spinal surgery and onset of disease was 34 months, with a wide
range of 0–156 months. Osteosynthesis material was present in twenty-two cases (76%). In 24 (83%) patients, additional surgery, such
as de´bridement or spondylodesis, was performed. Previous osteosynthesis material was removed in 17 of the 22 (77%) patients where
it was present. Total cure was reported in all patients, except one, after a mean duration of antibiotic therapy of 10.5 weeks (range,
2–28 weeks). In conclusion, spondylodiscitis due to P. acnes is an acute infection closely related to previous surgery. The most
prominent clinical feature is pain, whereas fever is rare, and the prognosis is very good.
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Introduction
Spondylodiscitis, together with septic discitis, vertebral oste-
omyelitis and epidural abscess, accounts for 2–7% of all cases
of osteomyelitis [1,2]. The incidence of postoperative infec-
tion is in the range 0–3% [3] or 0.7–0.8% with adequate anti-
biotic prophylaxis [4]. Treatment of spondylodiscitis usually
requires an invasive diagnostic approach and long-lasting anti-
biotic therapy, occasionally associated with surgical interven-
tion [1,2]. Prolonged hospital stay is often unavoidable and
comprises a major contributor to increased cost. The most
prevalent pathogens are Staphylococcus aureus and other
aerobic Gram-positive organisms [1,3–5]. In industrialized
countries, only a minority of cases are due to Gram-negative
aerobic organisms, tuberculosis, fungi, parasites [6] or
anaerobes [2,7]. Indeed, anaerobic disease is very rare and a
retrospective review of 253 cases of spondylodiscitis
revealed only two (0.8%) due to anaerobic bacteria [8].
These cases are mostly seen in postoperative, rather than in
non-operative, cases (17.4% vs. 5.1%) [9].
Propionibacterium acnes is a microaerophilic anaerobic,
Gram-positive rod [10] isolated from a wide variety of infec-
tions and usually found on the skin. The traditional view that
P. acnes is nonpathogenic for man, except in acne vulgaris,
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should be abandoned. The proportion of reported bone
infections caused by P. acnes varies in the range 2.8–12%
[11]. In the present study, we analysed all cases of spondylo-
discitis due to P. acnes in seven tertiary hospitals, comparing
risk factors, treatment and clinical outcomes with the
reports available in the literature.
Materials and Methods
Settings
This retrospective review was conducted in seven hospitals,
including the University Hospital of Geneva (Switzerland) and
six university hospitals in France (Garches, Nantes, Rennes,
Angouleˆme, Besanc¸on and Tours). All cases of microbiologi-
cally documented spondylodiscitis due to P. acnes as of May
2007 were retrieved from medical and laboratory records.
Case definition and parameters
The case definition required microbiological proof of P. acnes,
clinical evidence of infection, and radiological confirmation of
inflammation in a localized area of the spine. The patient
must not have been under antibiotic treatment. Microbiologi-
cal documentation required at least two different isolates of
the same P. acnes strain from intra-operative tissue speci-
mens and/or abscess aspiration under radiological control.
Propionibacterium acnes must have been the predominant
pathogen in all cultures that additionally showed an elevated
number of leukocytes as a hallmark of inflammation. The
presence of co-pathogens in one single sample did not
exclude the impact of P. acnes retrieved in several samples.
Each contributing centre used its own established protocols
for aerobic and anaerobic cultures, which were not changed
for the present study. Propionibacterium sp. other than P. acnes
were excluded.
Clinical parameters and cure rates
Descriptive statistics were used to assess the prevalence of
various clinical and laboratory parameters associated with
individual P. acnes spondylodiscitis (Table 1). Cure was
defined as an absence of clinical, biological and radiological
evidence of infection.
Results
Twelve males and 17 females with a median age of 42 years
(range, 14–78 years) were identified within the last 15 years.
All patients were immunocompetent except three: one
patient with non-insulin dependent diabetes, one on steroid
medication, and one patient with HIV. Only one patient had
concomitant inflammation elsewhere, and this was a male
with chronic prostatitis. No patient had pathology in the oral
cavity, the gastrointestinal tract, or on the skin. The most
frequent risk factor was surgery, present in the history of 28
of 29 (97%) patients, with osteosynthesis material present in
22 (76%) patients. The mean delay between spinal surgery
and onset of disease was 34 months (range, 0–156 months).
The median time to diagnosis was 4.7 months (range, 1 week
to 104 weeks).
All patients reported back pain as the main symptom, and
most were afebrile. The affected vertebral regions were
thoracic in 14 cases, lumbar in 13 cases, and thoraco-lumbar
in two cases. Three patients had a peripheral neurological
deficit, one had a motor deficit, and two had a sensory
deficit attributable to the infection; and six patients had an
epidural abscess (Fig. 1). A total leukocyte count >6 Giga/L
was present in 16 (56%) patients, and the mean C-reactive
protein. level was 31.7 mg/dL (range, 0.36–118 mg/dL), both
prior to eventual de´bridement. Blood cultures were not
performed for 13 patients. Blood cultures were negative for
P. acnes in the remaining patients, except for one. The
incubation time of the blood culture bottles was unknown.
In eight cases, the predominant P. acnes was associated with
other pathogens, including coagulase-negative Staphylococcus
(n = 4), Lactobacillus sp (n = 1), Pseudomonas aeruginosa
(n = 1), Enterococcus (n = 1) and Streptococcus of Lancefield
group F (n = 1). b-lactam antibiotics were the most frequently
used antimicrobial agent (15/29 patients). Among the oral
medications, fluoroquinolones were preferred. Only eight
patients received a single antimicrobial agent throughout the
entire course of treatment. In 24 (83%) patients, additional
surgery, such as de´bridement or spondylodesis, was
performed. Previous osteosynthesis material was removed in
17 of the 22 (77%) patients where it was present.
The mean follow-up period was 18 months (range,
4 months to 7 years). Total cure was reported in all patients,
except one, after a mean duration of antibiotic therapy of
10.5 weeks (range, 2–28 weeks). The mean duration of hos-
pitalization was 18 days (range, 4–63 days).
Discussion
Propionibacterium acnes spondylodiscitis is rare. To our
knowledge, the cohort of 29 patients involved in the present
study constitutes the largest case series of spondylodiscitis
due to P. acnes. As with every skin commensal, wound
contamination may lead to false-positive microbiological
findings. Carricajo et al. [12] reported that 18.5% of patients
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undergoing surgery for lumbar disk herniation revealed the
presence of P. acnes in intra-operative specimens. However,
this was an outbreak situation linked to contaminated lami-
nar airflow in the operating theatre [12]. McLorinan et al.
[13] demonstrated wound contamination due to P. acnes and
staphylococci in uninfected patients who underwent spinal
surgery. It was unusual in their study that skin samples with-
out underlying osteosynthesis material were vortexed and
exposed to ultrasonification [13], which are procedures
likely to enhance a microbiological result for skin commen-
sals. By contrast, patients in the present study were all
infected; intra-operative specimens showed clear-cut inflam-
mation with the presence of P. acnes in several specimens,
and the absence of an alternative predominant pathogen.
Hence, we have no doubt about the diagnosis of a true infec-
tion in the present study.
The present review of the literature resulted in 15
reports concerning spondylodiscitis due to P. acnes, which,
along with our own cases, are summarized in Table 1. Eleven
articles were case reports [14–24] and five were case series
[25–29], of which the largest involved four patients [26]. An
additional report [29] revealed insufficient information.
Most findings of P. acnes spondylodiscitis were consistent
with reports of aerobic spondylodiscitis, but differed in some
aspects. First, although spondylodiscitis can occur in children,
it is primarily a disease of the fifth or sixth decade of life
[30], and the median age of all patients in Table 1 was
44 years, which is lower than that reported in cases of aero-
bic disease with mean ages of 61 [31], 59 [1] or 64 years
[32], Second, only six patients in the present series had an
epidural abscess, which is a common feature in aerobic
disease [5,9]. For all of the patients listed in Table 1 (reports
in the literature and present study), the mean delay between
a previous invasive procedure and disease was 89 weeks
(range, 0–624 weeks), which is very close to the incubation
period, and was clearly longer than the average of 4 [9] or
7 weeks [8] reported for aerobic cases.
The median time to diagnosis of 4.7 months (range,
1 week to 24 months) was clearly longer than the average of
2.5 months [8] for aerobic cases.
In the present study, differences from other anaerobic
pathogens of spondlyodiscitis were also observed. Fever was
usually absent, unlike a retrospective report of non-P. acnes
anaerobic spondylodiscitis where fever was reported in 40%
of those affected [2]. Blood cultures were negative for all but
one patient in this series. In other reports, blood cultures
were positive in 15% of cases of anaerobic spondylodiscitis
[2], and 21% [8] or 56% [9] of cases of aerobic disease.
The site of infection among the present patients was
equally divided between the thoracic and lumbar spine, which
differs from other reports of anaerobic [2] or aerobic spinal
infections [1,8,31] where lumbar localization predominated.
The degree to which the reported clinical description is a
consequence of P. acnes itself or whether it would be true of
any aerobic skin organisms introduced during surgery is
unclear.
The characteristics of postoperative spondylodiscitis may
be similar to those presented in the present study [9,33],
although differences exist. The prolonged delay in arriving at
the correct diagnosis, the prolonged incubation time for
microbiological cultures [34], the high sensitivity to penicillin
[35], and the prolonged delay between surgical procedure
and infection highlight some of the key differences between
P. acnes and its aerobic counterparts.
The frequent risk factors for anaerobic disease include
poor oral hygiene, dental procedures, and bites [2,7]. In a
study of bacteraemia after endodontic procedures, samples
from the root canal of 26 subjects revealed anaerobic bac-
teria. Blood cultures were positive for the same organism
in 11 of these subjects [36]. The pathogenesis of P. acnes
spondylodiscitis infection appears to be different. We
found a strong causal correlation between P. acnes infec-
tion and previous invasive procedures in 97% of patients,
whereas ‘spontaneous’ infection has been reported to
occur more frequently with other anaerobes [2] or aero-
FIG. 1 Epidural abscess in spondylodiscitis due to Propionibacterium
acnes.
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bic pathogens [1,5,8,9,29]. Similar to our results, Nisbet
et al. [35] reported a post-craniotomy prevalence of 96%
in their neurosurgical patient population. The affinity for
surgical site infections can be explained by the nature of
P. acnes. Its microaerophilic character enables it to live on
skin and in sebaceous glands [10]. Propionibacterium acnes
can tolerate up to 100% oxygen [37] and is capable of
surviving up to 8 months under anaerobic conditions
in vitro, suggesting that it could also survive in human
tissue with low oxidation potential, such as the vertebral
disk [38]. Finally, it resists phagocytosis and can persist
intracellularly within macrophages [30]. Therefore, it is not
surprising that P. acnes infection correlates strongly with
invasive procedures such as neurosurgery [35], lumbar
puncture [19–21,23] and orthopaedic surgery [34]. Postop-
erative septic arthritis of the shoulder due to P. acnes may
become an emerging clinical entity [34].
For spondylodiscitis in general, there are no randomized or
prospective studies concerning the optimal choice and
duration of antibiotic treatment, as well as the role of surgery
[32]. In many patients (Table 1), an additional surgical
intervention such as debridement, spondylodesis or removal
of osteosynthesis material, was necessary. This correlates
with the reports concerning aerobic spondylodiscitis [8,9]. In
the past, P. acnes was usually sensitive to many antibiotics, but
the emergence of antibiotic resistance in P. acnes, and the
danger of propagation of untreated disease to the epidural
space with subsequent high morbidity and mortality [5],
necessitates the testing of isolated strains [30,39]. Intravenous
penicillin G and amoxicillin are the most frequently prescribed
antibiotics [35,40], followed by oral clindamycin or fluoro-
quinolones. Clindamycin is an appropriate oral treatment with
excellent bone-to-serum ratio, whereas b-lactams have an
inferior ratio [41]. By contrast to other anaerobes, P. acnes is
naturally resistant to metronidazole [19,39,42].
The duration of antibiotic treatment is often based on
past experience with aerobic pathogens [1,5], although sev-
eral reports describe anaerobic spondylodiscitis as being less
virulent, with a better prognosis than its aerobic counterpart
[2,25].
The minimal duration of P. acnes infection may be
6 weeks, and we do not believe that it can be shortened as
is implied by the case of the one patient referred to in
Table 1 [20] or a single retrospective study of intracranial
infections [35]. With the high likelihood of additional surgical
intervention for spondylodiscitis [1,2,8], and the slow growth
characteristics of P. acnes [9,11,22,25,27,34], a shorter dura-
tion of antibiotic therapy should not be attempted without
controlled studies and/or concomitant debridement. How-
ever, initial oral treatment should be possible, even if this
approach is not currently supported by randomized trials.
Prevention of infection after spinal surgery remains of utmost
importance [3,43,44] and, fortunately, the usual antibiotics
for preoperative prophylaxis cover P. acnes.
Cure was achieved in every patient in this series except
one, in contrast to cases of aerobic spondylodiscitis, where
50% of patients were reported to have complaints at follow-
up [3,31]. Mann et al. [45] reported sequelae in 55% of
patients. McHenry et al.[8] reported persistent disability in
more than 33% of patients, relapse in 14%, and death in 11%.
This difference may be a result of the younger age of patients
with postoperative infection due to P. acnes [9], which corre-
lates with the absence of co-morbidities among this popula-
tion, another hallmark of ‘spontaneous’ spondylodiscitis
[1,9,29]. In the present patient group, neurological deficits
attributable to the infection were present in only three (10%)
patients. In other reports of patients with anaerobic [2] or
aerobic disease, neurological deficit has been reported in 27%
[1], 39% [9] and even >50% [45] of patients.
In conclusion, spondylodiscitis due to P. acnes is strongly
related to previous intervention, and prevention remains
critical. The longer incubation period must be taken into
account with respect to microbiological cultures. The
prognosis appears excellent. The therapeutic approach is
not standardized, but antibiotic treatment is usually
prescribed for 6 weeks and often complemented by
surgery. Penicillin G, amoxicillin and clindamycin have
proven their efficacy in effecting a cure. As a result of the
rarity of spondylodiscitis due to P. acnes, only large
comparative prospective studies will be able to address
epidemiology and optimal therapy.
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